Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

The GOP-led House Judiciary Committee is investigating allegations that Pfizer delayed its COVID-19 vaccine testing until ...

Novavax CEO John Jacobs said in a statement that the approval was a "significant milestone" that solidifies a path for people to access the vaccine. The company missed out on the pandemic vaccine ...

More public events coming: Makary disclosed plans to hold public roundtables on cosmetics and drug regulation issues ... rethink the science around Covid vaccine efficacy now that the virus ...

Pfizer’s news about the effectiveness of its COVID-19 vaccine came nearly a week after ... he requested that he be relocated to Canada due to concerns that he could be investigated by the ...

A malaria vaccine developed by members of the University of Oxford team behind the AstraZeneca COVID-19 jab has ... answering concerns that the effectiveness of the vaccine may wane over time ...

When the Covid-19 pandemic hit ... reportedly reviewing NIH contracts related to mRNA vaccines. What’s your own view on their safety and efficacy? Well, I think there’s some well-known ...

As the 130+ vaccine ... effectiveness analysis will certainly evolve further; on 1 June, Gilead announced results from a phase 3 trial involving patients with moderate pneumonia resulting from ...